Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Work In Process: 2022-2025

Historic Work In Process for Fortress Biotech (FBIO) over the last 3 years, with Mar 2025 value amounting to $435,000.

  • Fortress Biotech's Work In Process fell 45.96% to $435,000 in Q1 2025 from the same period last year, while for Mar 2025 it was $435,000, marking a year-over-year decrease of 45.96%. This contributed to the annual value of $367,000 for FY2024, which is 58.48% down from last year.
  • Fortress Biotech's Work In Process amounted to $435,000 in Q1 2025, which was up 18.53% from $367,000 recorded in Q4 2024.
  • Fortress Biotech's 5-year Work In Process high stood at $2.7 million for Q2 2022, and its period low was $26,000 during Q3 2022.
  • Over the past 3 years, Fortress Biotech's median Work In Process value was $546,500 (recorded in 2023), while the average stood at $609,125.
  • As far as peak fluctuations go, Fortress Biotech's Work In Process skyrocketed by 1,661.54% in 2023, and later plummeted by 70.19% in 2024.
  • Fortress Biotech's Work In Process (Quarterly) stood at $395,000 in 2022, then surged by 123.80% to $884,000 in 2023, then crashed by 58.48% to $367,000 in 2024, then tumbled by 45.96% to $435,000 in 2025.
  • Its last three reported values are $435,000 in Q1 2025, $367,000 for Q4 2024, and $296,000 during Q2 2024.